Precipitating Hydrophobic Injectable Liquid - Neurovascular embolization plug
Australia TGA ARTG Registered Device · Culpan Medical Pty Ltd · MicroVention Europe SARL · Class III · Started September 28, 2021
Good Name: Culpan Medical Pty Ltd - Precipitating Hydrophobic Injectable Liquid - Neurovascular embolization plug
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- September 28, 2021
- Effective Date
- August 21, 2023
- Country
- France
- Address
- 30 bis rue du Vieil Abreuvoir, Saint-Germain-en-Laye, 78100
The PHIL is intended for use in the embolization of lesions in the peripheral and neurovasculature, including arteriovenous malformations and hypervascular tumors.
Access comprehensive regulatory information for Precipitating Hydrophobic Injectable Liquid - Neurovascular embolization plug in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Culpan Medical Pty Ltd, manufactured by MicroVention Europe SARL in France. The device registration started on September 28, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.